You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SY-4798

Showing 1 - 25 of 29
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in Shanghai (SY-4798)

Recruiting
  • Advanced Solid Tumor
  • SY-4798
  • Shanghai, China
    Shanghai East Hospital
Aug 10, 2022

Heart Failure Trial in Worldwide (Quadripolar LV Lead)

Recruiting
  • Heart Failure
  • Quadripolar LV Lead
  • Anchorage, Alaska
  • +114 more
Aug 9, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • SY-1425 (tamibarotene)
  • +2 more
  • Hartford, Connecticut
  • +25 more
May 4, 2022

Advanced Solid Tumor Trial in Shanghai (SY-5933)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 16, 2023

NSCLC Trial in Shanghai (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Sep 4, 2023

Sepsis Trial in Nanjing (SY-005, Placebo)

Recruiting
  • Sepsis
  • Nanjing, Jiangsu, China
    Zhongda Hospital，Affiliated to Southeast University
Feb 27, 2022

Advanced Solid Tumor Trial in Beijing (SY-3505)

Recruiting
  • Advanced Solid Tumor
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 15, 2023

Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

Recruiting
  • Non-small-cell Lung Carcinoma
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 11, 2023

Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Birmingham, Alabama
  • +4 more
Jul 12, 2022

Type 2 Diabetes Trial in China (SY-009 capsules)

Not yet recruiting
  • Type 2 Diabetes
  • SY-009 capsules
  • Bengbu, Anhui, China
  • +6 more
Jun 17, 2022

Type 2 Diabetes Trial in Nanjing (SY-008, SY-008 matching )

Completed
  • Type 2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing Gulou Hospital
May 17, 2022

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Type 2 Diabetes Trial in China (SY-009, SY-009 matching )

Completed
  • Type 2 Diabetes Mellitus
  • Hefei, Anhui, China
  • +3 more
Mar 21, 2022

Advanced Solid Tumor Trial in Shanghai (SY-4835)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Renji Hospital Affiliated to Shanghai Jiaotong University School
Mar 11, 2022

NSCLC Trial in Beijing (SY-3505)

Recruiting
  • Non-small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Mar 17, 2022

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 17, 2022

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Mobile Applications Trial in Leuven (Recipes consumption, Hydroponic unit)

Enrolling by invitation
  • Mobile Applications
  • Recipes consumption
  • Hydroponic unit
  • Leuven, Vlaams-Brabant, Belgium
    Departement Computerwetenschappen
May 26, 2023

Syphilis Trial in Paris (BPG, Doxycycline)

Recruiting
  • Syphilis
  • Paris, France
    Hôpital Cochin
Apr 6, 2022

Coronavirus Infection, Sepsis Trial in London (recombinant human annexin A5, Placebo)

Recruiting
  • Coronavirus Infection
  • Sepsis
  • recombinant human annexin A5
  • Placebo
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 23, 2021

Advanced Solid Tumors, Ovarian Cancer, Breast Cancer Trial in Canada, France, United States (SY-1365 (Part 1), Carboplatin,

Terminated
  • Advanced Solid Tumors
  • +2 more
  • SY-1365 (Part 1)
  • +5 more
  • Birmingham, Alabama
  • +19 more
Mar 5, 2021

Cerebral Apoplexy Trial in Chendu (SY-007)

Completed
  • Cerebral Apoplexy
  • Chendu, Sichuan, China
    West China Hospital of Sichuan University
Apr 30, 2021

Sepsis Trial in Nanjing (SY-005)

Completed
  • Sepsis
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
May 31, 2021

Type 2 Diabetes Trial in Beijing (SY-004, SY-004 matching )

Recruiting
  • Type 2 Diabetes Mellitus
  • Beijing, Beijing, China
    PLA General Hospital
May 15, 2021